norharman has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Voogd, NJ; Eguchi, K; Fujiwara, Y; Hayashida, A; Horlad, H; Kato, H; Losung, F; Mangindaan, RE; Rotinsulu, H; Takeya, M; Tsukamoto, S | 1 |
| Cheng, M; Kanno, Y; Koike, K; Li, H; Li, W; Nemoto, K; Sasaki, T; Wang, J; Zhang, X; Zhao, S | 1 |
2 other study(ies) available for norharman and Atherosclerosis
| Article | Year |
|---|---|
Manzamine A, a marine-derived alkaloid, inhibits accumulation of cholesterol ester in macrophages and suppresses hyperlipidemia and atherosclerosis in vivo.
Topics: Alkaloids; Animals; Atherosclerosis; Carbazoles; Cells, Cultured; CHO Cells; Cholesterol; Cholesterol Esters; Cricetinae; Cricetulus; Foam Cells; Humans; Hyperlipidemias; Lipoproteins, LDL; Macrophages; Mice; Mice, Inbred C57BL; Porifera; Sterol O-Acyltransferase; Sterol O-Acyltransferase 2 | 2013 |
Identification of Picrasidine C as a Subtype-Selective PPARĪ± Agonist.
Topics: Alkaloids; Animals; Atherosclerosis; Carbolines; Cholesterol; Glucose; Hypercholesterolemia; Indoles; Lipid Metabolism; Lipids; Mice; Molecular Structure; Picrasma; PPAR alpha; Transcription Factors | 2016 |